Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-018846
Filing Date
2013-04-01
Accepted
2013-04-01 06:53:05
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v338640_10k.htm 10-K 594122
2 EXHIBIT 31.1 v338640_ex31-1.htm EX-31.1 10083
3 EXHIBIT 31.2 v338640_ex31-2.htm EX-31.2 10083
4 EXHIBIT 32 v338640_ex32.htm EX-32 3871
  Complete submission text file 0001144204-13-018846.txt   3683829

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ovit-20121231.xml EX-101.INS 305650
6 XBRL TAXONOMY EXTENSION SCHEMA ovit-20121231.xsd EX-101.SCH 52725
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20121231_cal.xml EX-101.CAL 36041
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20121231_def.xml EX-101.DEF 212380
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20121231_lab.xml EX-101.LAB 385956
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20121231_pre.xml EX-101.PRE 270957
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28347 | Film No.: 13728871
SIC: 2834 Pharmaceutical Preparations